Skip to main content

Ocular Surface Diseases

Guest Editors:
Bharat Gurnani: Om Prakash Eye Institute, India
Ho sik Hwang: Catholic University of Korea, Seoul
Rohan Bir Singh: Schepens Eye Research Institute of Massachusetts, USA


 This BMC Ophthalmology collection is focused on the debilitating chronic diseases of the ocular surface, with the aim to collate recent advances and to comprehensively review developments in Ocular Surface Disaese research.



Meet the Guest Editors

Back to top

Bharat Gurnani: Om Prakash Eye Institute, India

Dr. Bharat Gurnani is a Cataract, Cornea, External Diseases, Ocular Surface, Trauma and Refractive Surgery consultant at Om Prakash Eye Institute, Amritsar, Punjab, India and has keen interest in research and publication. He has published more than 200 peer reviewed articles in various international and national journals and has reviewed over 350 papers for various journals. His keen interests are microbial keratitis, keratoconus, dry eye, ocular trauma and lamellar surgeries.
 

Ho sik Hwang: Catholic University of Korea, Seoul

Dr. Ho sik Hwang, MD, PhD works as an associate professor of ophthalmology at Catholic university of Korea, Seoul. His research areas of interest include dry eye syndrome, Meibomian gland, conjunctival goblet cell and multifocal intraocular lens.

 

Rohan Bir Singh: Schepens Eye Research Institute of Massachusetts, USA

Dr. Rohan Bir Singh is a Fellow at the Laboratory of Corneal Immunology, Transplantation and Regeneration at the Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School. He graduated from the Government Medical College & Hospital, Panjab University, India. His research interests include dry eye disease and corneal transplantation immunology, clinical manifestations of ocular graft-versus-host disease and epidemiology of corneal disorders in the United States. Dr. Singh is also a visiting lecturer at the Division of Ophthalmology and Vision Sciences, Adelaide Medical School, the University of Adelaide, Australia. He has published more than 50 peer reviewed publications and chapters and edited three textbooks. He is a member of the editorial board of BMC Ophthalmology, Therapeutic Advances in Ophthalmology and Frontiers in Ophthalmology and has peer reviewed articles for more than 20 journals.





About the collection

Ocular surface diseases (OSD) such as dry eye disease or anterior blepharitis have become more prevalent, causing visual disturbances, ocular discomfort in patients; however, these disorders continue to remain undiagnosed in majority of the populace. The evidence suggests that there is an increasing incidence of  ocular allergies requiring long-term management. 

In the past two decades,  there has been an increased research focus on the underlying pathophysiology, diagnosis and treatment of these diseases. Novel biomarkers found in the tear fluid and alterations in the ocular microbiome are increasingly gaining recognition as possible diagnostic tools and hence gaining interest of research groups globally.

We are launching a collection focused on the debilitating chronic diseases of the ocular surface, with the aim to collate recent advances and to comprehensively review developments in OSD research.

We are particularly interested in research on the pathogenesis of OSD as well as in studies describing novel patient-centric treatment strategies. We will be considering both basic and clinical research but strongly encourage authors to submit their experimental work to this collection. We are also interested in high-quality systematic reviews and meta-analyses from this field.

Potential topics include but are not limited to the following:

● Advances in treatment of dry eye disease, Meibomian gland dysfunction and blepharitis 

● Basic research focused on the pathophysiology of OSD

● Newer imaging modalities for clinical diagnostics of OSD

● Ocular surface and tear biomarkers

● OSD as the consequence of ophthalmic surgery 

● The ocular microbiome

● Ocular surface and aging

  1. To evaluate the efficacy and safety of peribulbar triamcinolone acetonide injection for treating ocular myasthenia gravis (OMG), with a comparison of traditional oral drug therapy.

    Authors: Minghua Shi, Zhuneng Lu, Aijiao Qin, Jing Cheng, Simin Chen and Yiqiao Xing
    Citation: BMC Ophthalmology 2024 24:33
  2. This study aims to assess how Romanian medical students suffer from dry eye disease symptoms, establish the prevalence and severity of dry eye (DE) symptoms and identify potential risk factors.

    Authors: Laura Denisa Preoteasa and Dana Preoteasa
    Citation: BMC Ophthalmology 2024 24:12
  3. To investigate the validation of phenol red thread (PRT) test in a Chinese population by evaluating the intraobserver repeatability and interobserver reproducibility, determining correlations between the PRT t...

    Authors: Yiran Hao, Tao Jin, Lei Zhu, Mengnan Zhao, Silu Wang, Zhongying Li, Lei Tian and Ying Jie
    Citation: BMC Ophthalmology 2023 23:498
  4. Inflammatory bowel disease (IBD) is associated with lacrimal gland dysfunction and ocular inflammation. The objective of this research was to elucidate the temporal relationships between IBD, dry eye disease (...

    Authors: Yi-Ting Ko, Yu-Ming Wu, Hsiang-Ling Wu, Shih-Chung Lai, Ying-Xiu Dai, Tzeng-Ji Chen, Yih-Giun Cherng, Ying-Hsuan Tai and Chia-Yu Kao
    Citation: BMC Ophthalmology 2023 23:415
  5. Peripheral ulcerative keratitis (PUK) is a group of inflammatory corneal ulcers with stromal thinning and peripheral localization. Amniotic membranes (AM) are used for their anti-inflammatory and healing prope...

    Authors: Clara Bertret, Loïc Leveziel, Juliette Knoeri, Cristina Georgeon, Céline Jamart, Nacim Bouheraoua and Vincent Borderie
    Citation: BMC Ophthalmology 2023 23:387
  6. Ocular surface squamous neoplasia (OSSN) comprises a wide spectrum of squamous tumors, from which corneal/conjunctival intraepithelial neoplasia (CIN) is the most common one. The classic treatment is complete ...

    Authors: Beatriz Alvarado-Castillo, Francisco J. Santa Cruz-Pavlovich, Celia Gonzalez-Castillo, Isaac Alejandro Vidal-Paredes, Leonel Garcia-Benavides, Maria Elena Rosales-Gradilla and Jose Navarro-Partida
    Citation: BMC Ophthalmology 2023 23:335
  7. The aim of this work is to evaluate the safety and efficacy of repeated sessions of photo-activated chromophore for keratitis-cross linking (PACK-CXL) window absorption (WA) for the treatment of resistant bact...

    Authors: Mohammed M. Mahdy Tawfeek, Hanan Mohamed Abdel Hamid Ahmed, Ashraf Bor’i and Ahmed M. Nashaat Ali Rady
    Citation: BMC Ophthalmology 2023 23:333
  8. Due to technological advancements, surgical invasiveness has been reduced. However, cataract surgery has been implicated in causing postoperative inflammation, including dry eye syndrome. The innate immune sys...

    Authors: Hiroki Maehara, Koki Norikawa, Keiichiro Tanaka, Yutaka Kato, Akihito Kasai, Tomoko Omori, Takeshi Machida, Hideharu Sekine and Tetsuju Sekiryu
    Citation: BMC Ophthalmology 2023 23:329
  9. To observe the distribution characteristics of corneal higher-order aberrations (HOAs) in cataract patients, and analyze the relationship of HOAs with patients’ age and ocular biometric parameters.

    Authors: Suowang Zhou, Xu Chen, Julio Ortega-Usobiaga, Hansong Zheng, Wenjing Luo, Biyue Tu and Yong Wang
    Citation: BMC Ophthalmology 2023 23:313
  10. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and extremely serious drug-induced dermatological disorders. The ocular surface condition at the early stage has been little studied...

    Authors: Yingyi Liu, Jianing Feng, Yuerong Ren, Wen Shi, Huanmin Kang, Yingqian Peng, Yixin Tan, Ruifang Wu, Guiying Zhang and Yan He
    Citation: BMC Ophthalmology 2023 23:297
  11. Keratoconus is a degenerative disorder of the cornea leading to a protrusion and thinning with loss of visual acuity. The only treatment to halt the progression is corneal crosslinking (CXL), which uses ribofl...

    Authors: Magali M. S. Vandevenne, Tos T. J. M. Berendschot, Bjorn Winkens, Frank J. H. M. van den Biggelaar, Nienke Visser, Mor M. Dickman, Robert P. L. Wisse, Robert-Jan H. J. Wijdh, Abhijit Sinha Roy, Rohit Shetty and Rudy M. M. A. Nuijts
    Citation: BMC Ophthalmology 2023 23:224
  12. To assess the prevalence of dry eye disease (DED) in the Uyghur population in Hotan, Xinjiang, and to identify risk factors associated with this disorder.

    Authors: Xiaolong Li, Zhen Wang, Jingyu Mu, Hamila Puerkaiti, Ayinu Nulahou, Jie Zhang, Yong Zhao, Qi Sun, Yuanyuan Li, Yan Wang and Yunxian Gao
    Citation: BMC Ophthalmology 2023 23:214
  13. The long-term use of visual display terminals (VDT) is linked to an increased risk of dry eye disease (DED). Numerous studies have indicated that ocular mucins play a vital role in the pathogenesis of DED. The...

    Authors: Hongyu Duan, Tingting Yang, Yifan Zhou, Baikai Ma, Lu Zhao, Jiawei Chen and Hong Qi
    Citation: BMC Ophthalmology 2023 23:189
  14. Severe ocular surface disorders are one of the major blinding diseases, and a paucity of original tissue obscures successful reconstruction. We developed a new surgical technique of direct oral mucosal epithel...

    Authors: Yuan-Fang Zhu, Wen-Ya Qiu, Ye-Sheng Xu and Yu-Feng Yao
    Citation: BMC Ophthalmology 2023 23:145
  15. This study aimed to explore the associations between Demodex infestation and the ocular surface characteristics of meibomian gland dysfunction (MGD) in different age groups, to further understand the effect of De...

    Authors: Xiaowen Sun, Zhanglin Liu, Shengshu Sun, Shaozhen Zhao, Xiaomin Zhang and Yue Huang
    Citation: BMC Ophthalmology 2022 22:388